Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
22.86
-0.26 (-1.12%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Zymeworks Employees
Zymeworks had 243 employees as of March 31, 2026. The number of employees decreased by 56 or -18.73% compared to the same quarter last year.
Employees
243
Change
-56
Growth
-18.73%
Revenue / Employee
$334,416
Profits / Employee
-$422,453
Market Cap
1.64B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| Ascentage Pharma Group International | 767 |
| Recursion Pharmaceuticals | 600 |
| AbCellera Biologics | 562 |
| Maravai LifeSciences Holdings | 416 |
| Innoviva | 159 |
| Maze Therapeutics | 141 |
| MapLight Therapeutics | 133 |
ZYME News
- 5 days ago - Zymeworks management to meet with B. Riley - TheFly
- 10 days ago - Zymeworks to Report Second Quarter 2026 Financial Results on August 6, 2026 - GlobeNewsWire
- 19 days ago - Zymeworks price target raised to $31 from $28 at Truist - TheFly
- 26 days ago - Zymeworks price target raised to $37 from $34 at Wells Fargo - TheFly
- 26 days ago - Zymeworks price target raised to $37 from $35 at Citi - TheFly
- 27 days ago - Zymeworks Transcript: M&A announcement - Transcripts
- 27 days ago - Zymeworks Press release: M&A announcement - Filings
- 27 days ago - Zymeworks Slides: M&A announcement - Filings